A patient treated for 4 months with hydroxycarbamide (hydroxyurea) for chronic myelomonocytic leukemia was admitted to hospital for recently developed severe dyspnea and acute respiratory failure. The computed tomographic scan of the chest showed diffuse ground glass opacities, some centrilobular low-density nodules (resembling hypersensitivity pneumonitis-like pattern), and minimal interstitial reticulation of the subpleural region. The analysis of bronchoalveolar lavage fluid excluded infection, as did serological examinations. The patient was started on oxygen therapy and with relief of thrombocytopenia and suspected hemolytic anemia, hydroxyurea treatment was discontinued. The patient underwent steroid therapy, with a rapid progressive improvement of clinical and radiological features. As hydroxyurea is increasingly used for a number of systemic disorders, physicians must be aware of its potential lung toxicity, requiring immediate cessation of the treatment and empiric corticosteroid therapy.

Bargagli, E., Palazzi, M., Perri, F., Torricelli, E., Rosi, E., Bindi, A., et al. (2017). Fibrotic Lung Toxicity Induced by Hydroxycarbamide. IN VIVO, 31(6), 1221-1223 [10.21873/invivo.11194].

Fibrotic Lung Toxicity Induced by Hydroxycarbamide

Bargagli, Elena;Palazzi, M.;Torricelli, Elisa;Rosi, Eleonora;Pistolesi, M.;
2017-01-01

Abstract

A patient treated for 4 months with hydroxycarbamide (hydroxyurea) for chronic myelomonocytic leukemia was admitted to hospital for recently developed severe dyspnea and acute respiratory failure. The computed tomographic scan of the chest showed diffuse ground glass opacities, some centrilobular low-density nodules (resembling hypersensitivity pneumonitis-like pattern), and minimal interstitial reticulation of the subpleural region. The analysis of bronchoalveolar lavage fluid excluded infection, as did serological examinations. The patient was started on oxygen therapy and with relief of thrombocytopenia and suspected hemolytic anemia, hydroxyurea treatment was discontinued. The patient underwent steroid therapy, with a rapid progressive improvement of clinical and radiological features. As hydroxyurea is increasingly used for a number of systemic disorders, physicians must be aware of its potential lung toxicity, requiring immediate cessation of the treatment and empiric corticosteroid therapy.
2017
Bargagli, E., Palazzi, M., Perri, F., Torricelli, E., Rosi, E., Bindi, A., et al. (2017). Fibrotic Lung Toxicity Induced by Hydroxycarbamide. IN VIVO, 31(6), 1221-1223 [10.21873/invivo.11194].
File in questo prodotto:
File Dimensione Formato  
Bargagli et al_In vivo_2017.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 139.6 kB
Formato Adobe PDF
139.6 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1023649